Adam Feuerstein of TheStreet.com seems to think so, in an analysis flagged on Gary Schwitzer's HealthNewsReview.org. Feuerstein dissects an Osiris Therapeutics press release from last week and accuses the company of falsely claiming success in a study of its stem cell therapy Prochymal: "Figuring out Osiris' deception wasn't that difficult if you know how to parse the language of clinical trial results and look at independent sources of information for the truth."
